Advanomics: Anticancer Compound, ADVA-27A Patent Transaction


Back to Market   点击查看专利   Bid-Ask™ Market Brochure


Public Patent Transaction 0152 on Ocean Tomo Bid-Ask™ Market

Public Patent Transaction Advanomics anticancer compound, adva-27a patent sold for $17,142,499

Public Patent Transaction, 0152 reported on the Ocean Tomo Bid-Ask™ Market relates to a divestiture of 1 patent. Advanomics sold the anticancer compound, adva-27a patent to Sunshine Biopharma, Inc. for $ 17,142,499

Patent Resource Link